tirzepatide and sleep FDA Approves Zepbound for Apnea Patients With Obesity Studies Show Weight Loss Drug

Obesity Management Retatrutide is most notably being developed for weight loss

Endocrinology2011 Aug;152(8):3103-12

Prescription medication is prescribed at a medical providers discretion if clinically appropriate

Secondary outcomes were urine output, 24-hour urinary sodium, estimated glomerular filtration rate, HbA1c, mean arterial pressure, Child Turcotte Pugh (CTP), model for end stage liver disease (MELD) scores and survival at 6-months, incidence of acute kidney injury (AKI), infections, hepatic encephalopathy, hyponatremia, hypokalemia, hepatocellular carcinoma, diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic coma

Nutritional counseling Our team provides science-backed guidance on healthy eating habits and meal planning

Mauvais-Jarvis et al., 2013)